Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 7Unknown 3Terminated 3Active not recruiting 2Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Precancerous Conditions 4Salivary Gland Malignant Neoplasms 1Rare Malignant Neoplasm 1Pediatric Cancer Chemotherapy-Related Symptoms Anxiety 1Older Patients 1Lymphoproliferative Disorders 1Lymphatic Metastasis 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Indications for Laparoscopic Thoracic and Abdominal Surgery in Children 1Colorectal Neoplasms 1Colonic Neoplasms 1Cervical Cancer Screening 1Cancer-related Problem/Condition 1Advanced Malignant Neoplasm 1

Interventions

Irinotecan 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Advanced Malignant Neoplasm × Other neoplasm × Clear all
NCT06394713 2024-05-01

A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors

Qilu Pharmaceutical Co., Ltd.

Phase 1/2 Not yet recruiting
60 enrolled
Other neoplasm

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡